[CH3:1][C:2]1([CH3:14])[O:6][C@@H:5]([CH2:7][N:8]2[CH:12]=[C:11]([I:13])[CH:10]=[N:9]2)[CH2:4][O:3]1.[CH2:15]1COCC1.[Li+].CC([N-]C(C)C)C.C1CCCCC1.CI.[NH4+].[Cl-]>>[CH3:1][C:2]1([CH3:14])[O:6][C@@H:5]([CH2:7][N:8]2[C:12]([CH3:15])=[C:11]([I:13])[CH:10]=[N:9]2)[CH2:4][O:3]1A solution of 1-{[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl}-4-iodo-1H-pyrazole (700 mg, 2.27 mmol) in THF (6 mL, 70 mmol) was cooled to −78° C., and 1.5 M of LDA in cyclohexane (4.5 mL, 6.8 mmol) was added. After stirring for 1 h, methyliodide (1.41 mL, 22.7 mmol) was added slowly, and the mixture was stirred at −78° C. for 1 h. Sat. NH4Cl was added to quench, and the organic solvent was removed in vacuo. The material was extracted with DCM and water, and the organic layer purified via column chromatography, eluting with 5-10% EtOAc/hexanes. The fractions containing the pure product were concentrated in vacuo to afford the title compound as a white solid. MS (ES+): m/z=323.06 (100) [MH+]. HPLC: tR=1.20 min (polar—3 min, UPLC-ACQUITY).
Loading…
